RSS

Topic: GlaxoSmithKline plc

  

Paxil Once Again Stalks Potential Victims

The safety of drugs these days is a major issue not only with patients, but in the legal arena as med mal attorneys fight for justice for victims. READ»

Paxil Once Again Stalks Potential Victims

The safety of drugs these days is a major issue not only with patients, but in the legal arena as med mal attorneys fight for justice for victims. READ»

GENERIC: How generate image brand distinction in a world where all have the same name?

                                                                                                        Read listening Mozart  ...READ»

Pharmaceutical blogs bring customers closer

In the super-regulated world of pharmaceuticals, some of the world’s largest corporations are using digital media to get closer to customers and advocates. GlaxoSmithKline and Johnson & Johnson are using blogs to engage in ...READ»

chest
VACCINE   |  Comment

GlaxoSmithKline Fights Malaria in Africa with Satellites

Malaria kills one million people a year, most of them children in Africa's so-called Malaria Belt (the sub-Saharan region). In partnership with the Gates Foundation, pharmaceuticals giant GlaxoSmithKline is preparing an ambitious ...READ»

Do you Have a Coach Yet?

The business and life coaching industry has skyrocketed in size over the past seven years. Places like Coach U and the ICF are cranking out coaches faster than business schools used to produce MBA's. According to Coach U, companies ...READ»

no-smoking-sign

GlaxoSmithKline Signs $540 Million Deal for Nicotine Vaccine

Four years ago, the startup Nabi Biopharmaceuticals began testing a promising nicotine vaccine called NicVax with the aid of $4.1 million in funding from the National Institutes of Health. Earlier today, the vaccine received a booster ...READ»

Medicine Man: Andrew Grant

What makes you feel good now looks even better.READ»

LEADERSHIP   |  Comment

Openness, Generosity, and Accountability

Where do those attributes fit in today's bustling business world? Leaders at a recent conference learned firsthand.READ»

Ivan Glickman
DESIGN   |  4 comments

Buy.ology: Why We Buy What We Do

It seems that I spend a great deal of time these days talking about the subconcious emotional drivers of designs. It turns out that there are very good reasons we all "buy" what we do. Reasons that are tied into our biology, ...READ»

HEALTH CARE   |  Comment

Can CEOs Cure Cancer?

Big Pharma execs may not know more about the disease than the rest of us, but a group of them are using their power to fight it.READ»

Social Capitalists: Profiles

Path (Program for Appropriate Technology in Health) Founded: 1977 Seattle, Washington Christopher J. Elias, President www.path.org Entrepreneurship: A Innovation: A+ Social Impact: A+ Aspiration: A- Sustainability: A- ...READ»

Traditional Chasm Market Segmentation - Moving to the Max Segmentation Strategy

 Whole books have been written about market segmentation, so it is difficult to summarize it on a page. One of the leading segmentation methodologies, that became part of teaching at the Harvard Business School, is what we lived ...READ»

Spare No Expense

Even the staunchest budget "hawk" understands that you can't cost-cut your way to growth.READ»

   |  Comment

When The Thrill Is Gone, So Are They

Do you help your employees find the work they love to do? It may not always be easy, and you may even risk losing some of them. But if you don’t partner with your talented employees to find work they are passionate about, you will no doubt lose them anyway.READ»

Individual Health Insurance Reform Weekly : EasyToInsureME : July 23, 2009

Last week will go down as a truly significant week in health care reform. The House leadership unveiled its 1,000+ page bill and announced that the three committees of jurisdiction would immediately begin mark-up sessions designed to get a composite bill to the House floor by the end of July. Late last week the House Ways and Means Committee approved the House bill 23 to 18READ»

   |  11 comments

To Vaccinate, or not to Vaccinate

Nothing causes an uproar in this country more than the sex lives of young girls: Who's doing it? And where? How many? And why? How young? And what can be done about it? There's always some crisis when it comes to women and sex. But ...READ»

Project: You

Sure, most work today is project work. But which projects are worth working on? And how does a series of projects become a career?READ»

Genealogy, Man Holding Baloons, DNA, Cells
GENETICS   |  3 comments

The Gene Bubble: Why We Still Aren't Disease-Free

When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.READ»

Wyeth BioPharma Lab

Wyeth's Multibillion-dollar Biotech Bet

Drugmaker Wyeth bet billions on biotech, transforming its culture and boosting profits.READ»

Now That We Have Your Complete Attention ...

Here's Fast Company's eight-point program for presentations guaranteed to keep your listeners on the edge of their seats.READ»

GEAR   |  1 comment

The Digital Darkroom

Sometimes, the best way to help people get the picture is to take one. Now that digital photography is finally ready for the world of work, we've assembled pixel-perfect tools for outfitting your digital darkroom.READ»

Outting Imus

If I were Don Imus I would stay home for a while. Not just in the house, but in bed, with the shades drawn. With all the invectives being slung around -- about his comb-over, his lack of sexual prowess, his tired rants -- it's ...READ»

People and Technology - MicroStrategy Inc.

"We live in an ignorant world. Our mission is to purge that ignorance."READ»

Is Bigger Better?

Unit of OneREAD»